Curative Therapy

Curative Therapy is a therapeutic intervention within the domain of Sickle Cell Disease research that belongs to the class of disease-modifying treatments and is distinguished by its capacity to achieve complete and durable eradication of the disease pathophysiology through definitive correction of the underlying genetic or hematologic defect.

5.2K

Publications

256.7K

Citations

32.6K

Authors

5.2K

Institutions

Publications per year

2017–2026

1.8K

Variants

Curative Therapies

Authors

32.6K

  1. YR
    Yasushi Rino

    Yokohama City University, Japan

    20 publications · 412 citations

    14

    h-index

  2. TA
    Toru Aoyama

    Yokohama City University, Japan

    18 publications · 484 citations

    14

    h-index

  3. MK
    Masatoshi Kudo

    Kindai University, Japan

    14 publications · 1.8K citations

    12

    h-index

  4. BN
    Bipin N. Savani

    Vanderbilt University Medical Center, United States

    12 publications · 701 citations

    12

    h-index

  5. NY
    Norio Yukawa

    Yokohama City University, Japan

    14 publications · 259 citations

    12

    h-index

1–5 of 32.6K

Venues

  1. PubMed

    Repository · 513 publications · 18.3K citations

    64

    h-index

  2. Cancer

    127 publications · 10.8K citations

    56

    h-index

  3. Journal of Clinical Oncology

    117 publications · 13.6K citations

    53

    h-index

  4. PLoS ONE

    76 publications · 3.8K citations

    37

    h-index

  5. British journal of surgery

    BJS · 50 publications · 7.7K citations

    35

    h-index

1–5